Diagnosis and staging of pancreatic cancer: Imaging evaluations-pancreatic protocol CT and MRI, PET-CT

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer and fourth leading cause of cancer mortality in the USA (Siegel et al., CA Cancer J Clin 70:7-30, 2020). Early diagnosis, accurate staging, and appropriate treatment are essential in management of patients with pancreatic cancer, which require a multidisciplinary approach. Imaging is crucial in detection and staging of pancreatic cancer. We will review the role and value of different imaging modalities in diagnosis, staging, and follow-up of pancreatic cancer.

Original languageEnglish (US)
Title of host publicationPancreatic Cancer
Subtitle of host publicationA Multidisciplinary Approach
PublisherSpringer International Publishing
Pages51-66
Number of pages16
ISBN (Electronic)9783031057243
ISBN (Print)9783031057236
DOIs
StatePublished - Oct 22 2022

Keywords

  • American Joint Committee on Cancer (AJCC)
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • Positron Emission Tomography/Computed Tomography (PET/CT)

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Diagnosis and staging of pancreatic cancer: Imaging evaluations-pancreatic protocol CT and MRI, PET-CT'. Together they form a unique fingerprint.

Cite this